End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | -.--% | +5.26% | -.--% |
Apr. 30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
Sales 2024 * | 11.6M 7.72M | Sales 2025 * | 3.6M 2.39M | Capitalization | 23.88M 15.89M |
---|---|---|---|---|---|
Net income 2024 * | -8M -5.32M | Net income 2025 * | -13M -8.65M | EV / Sales 2024 * | 1.44 x |
Net cash position 2024 * | 7.2M 4.79M | Net cash position 2025 * | 9.2M 6.12M | EV / Sales 2025 * | 4.08 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-2.22
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.58% |
Latest transcript on Syntara Limited
1 week | +5.26% | ||
1 month | +17.65% | ||
3 months | -16.67% | ||
6 months | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 03-03-11 |
Director of Finance/CFO | 67 | 02-11-30 | |
Jana Baskar
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CEO | Chief Executive Officer | 62 | 03-03-11 |
Director of Finance/CFO | 67 | 02-11-30 | |
Kathleen Metters
CHM | Chairman | 66 | 17-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.02 | -.--% | 754,570 |
24-05-30 | 0.02 | -4.76% | 63,950 |
24-05-29 | 0.021 | -.--% | 90,673 |
24-05-28 | 0.021 | +10.53% | 884,358 |
24-05-27 | 0.019 | -.--% | 3,645,404 |
End-of-day quote Australian S.E., May 30, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 15.86M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- SNT Stock